CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. JOINT OWNERSHIP MANAGEMENT AGREEMENTJoint Ownership Management Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
Contract Type FiledMay 12th, 2022 Company Industry
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDMENT TO / JOINT OWNERSHIP MANAGEMENT...Joint Ownership Management Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
Contract Type FiledMay 12th, 2022 Company IndustryTHIS AMENDMENT is entered into this 10th day of March 2022 (the “Effective Date of the Amendment”), by and between ChromaDex, Inc. (hereinafter referred to as “CHROMADEX”) and The Queen’s University of Belfast (hereinafter referred to as the “COMPANY”).